90.12
price up icon0.46%   0.41
pre-market  Pre-mercato:  92.12   2.00   +2.22%
loading

Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
7.23%
211.37
197.12 190.57 148.33 138.04
Operating Expenses
15.53%
197.48
170.93 194.95 168.85 132.87
Benefits Costs and Expenses
13.39%
200.85
177.13 204.34 179.83 140.33
Costs And Expenses
15.53%
197.48
170.93 194.95 168.85 132.87
Depreciation and Amortization
1.70%
23.28
22.89 22.60 15.75 14.70
Operating Income/Loss
46.96%
13.89
26.19 -4.378 -20.52 5.169
Interest And Devidend Income
6.14%
2.784
2.623 - - -
Income/Loss From Continuing Operations Before Tax
47.34%
10.53
19.99 -13.76 -31.50 -2.287
Income Tax Expense/Benefit
54.11%
1.976
4.306 -3.486 -7.332 -
Income/Loss From Continuing Operations After Tax
45.48%
8.549
15.68 -10.28 -24.17 -2.287
Net Income/Loss
45.48%
8.549
15.68 -10.28 -24.17 -2.287
Preferred Stock Dividends And Other Adjustments
0.25%
0.407
0.406 0.406 0.406 0.407
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.16%
19.83
19.61 0.043 19.40 19.32
Diluted Average Shares
1.31%
20.31
20.05 0.043 19.40 19.32
Basic Earnings Per Share
47.14%
0.37
0.70 -0.55 -1.27 -0.14
Diluted Earnings Per Share
47.83%
0.36
0.69 -0.55 -1.27 -0.14
Undistributed Earnings/Loss Allocated To Participating Securities, Basic
47.63%
0.819
1.564 - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
37.77%
1.226
1.97 0.406 0.406 0.407
$28.85
price up icon 2.61%
$17.52
price down icon 1.02%
drug_manufacturers_specialty_generic RDY
$14.18
price down icon 0.35%
$10.68
price up icon 0.47%
$132.81
price down icon 0.25%
$313.22
price down icon 0.28%
Capitalizzazione:     |  Volume (24 ore):